(Reuters) – Abbott Laboratories’ rapid COVID-19 antigen test is highly likely to correctly detect if people have ever contracted the virus and could help with earlier isolation, according to the U.S.

The U.S. Food and Drug Administration has issued an emergency use authorization for a new novel coronavirus test from Abbott Laboratories. Results from the speedy test come back in as little as five ...

Gov. Phil Murphy announced at his daily COVID-19 briefing on Tuesday afternoon that Bergen County will be the site for a new rapid test from Abbott Laboratories. Last week, the U.S. Food and Drug ...

Dec. 21—The company that operates a Maine factory making a widely used rapid test for COVID-19 said it would increase production by 40 percent in January amid widespread shortages of the tests before ...

CNN — Abbott Labs got emergency approval from the US Food and Drug Administration for its rapid antigen test, which can detect a Covid-19 infection in 15 minutes. The test is a "game changer," ...

Lab officials say Abbott’s rapid COVID-19 test poses a greater risk of infection to those administering it than other types of diagnostic tests, Kaiser Health News reported. HHS has said the test ...

Demand for COVID tests has fluctuated during the course of the pandemic and Abbott has recently seen demand decline for its BinaxNOW rapid antigen tests. In the first quarter, the company reported ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The North Chicago company said ...